Seropositive Rheumatoid Arthritis is a debilitating, systemic disease. Its symptoms go far beyond what the eye can see.

A new study finds that KL-6 and hSP-D levels can help predict progression of interstitial lung disease in patients with ...

Rheumatoid arthritis (RA) patients face very different risks for cardiovascular disease and events depending on their body ...

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

A novel method combining EHR and GWAS data improves prediction of autoimmune disease progression from preclinical stages, ...

Psoriatic arthritis is a combination of psoriasis and arthritis symptoms. You may have skin and nail changes, joint pain and ...

Increasing wildfire incidence, along with greater overall air pollution, may be contributing to risks for rheumatoid ...

Based on clinical trial data, abatacept was not associated with increased malignancy risks in RA or PsA; observational data indicated a higher risk vs other b/tsDMARDs.

Janus kinase (JAK) inhibitors are associated with an increased risk for lung cancer but not overall cancer among older patients in the United States with rheumatoid arthritis (RA), according to study ...

Sotyktu significantly outperformed placebo for the treatment of psoriatic arthritis in a phase 3 trial, meeting key endpoints ...

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...

The recombinant zoster vaccine protects against HZ and PHN in older patients with RA, with no increased risk for RA flares found within 30 days of vaccination.